Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Systemic capillary leak syndrome preceding plasma cell leukaemia.

Ghosh K, Madkaikar M, Iyer Y, Pathare A, Jijina F, Mohanty D.

Acta Haematol. 2001;106(3):118-21.

PMID:
11713377
2.
3.

Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone.

Christou L, Hatzimichael E, Chaidos A, Tsiara S, Bourantas KL.

Eur J Haematol. 2001 Jul;67(1):51-3.

PMID:
11553267
4.

Evaluation of intensive chemotherapy in AL amyloidosis: usefulness of flow cytometric analysis of plasma cells in bone marrow.

Matsuda M, Gono T, Shimojima Y, Sakashita K, Koike K, Ikeda S.

Amyloid. 2003 Dec;10(4):250-6.

PMID:
14986484
5.

Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.

Ahmad I, Islam T, Chanan-Khan A, Hahn T, Wentling D, Becker JL, McCarthy PL Jr, Alam AR.

Bone Marrow Transplant. 2002 Apr;29(7):577-80.

6.

A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.

Sekiguchi Y, Shimada A, Wakabayashi M, Sugimoto K, Tomita S, Izumi H, Nakamura N, Sawada T, Ohta Y, Komatsu N, Noguchi M.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6313-22. eCollection 2014.

7.

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.

Rawstron AC, Davies FE, DasGupta R, Ashcroft AJ, Patmore R, Drayson MT, Owen RG, Jack AS, Child JA, Morgan GJ.

Blood. 2002 Nov 1;100(9):3095-100.

8.

Long-term disease-free survival in a primary plasma cell leukemia treated by VAD, autologous PBSC transplantation, and IFN-alpha.

Büchler T, Ferra C, Domingo A, Gallardo D, Sarra J, Grańena A.

Am J Hematol. 2002 Sep;71(1):62. No abstract available.

10.

Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).

Rechner I, Brito-Babapulle F, Fielden J.

Hematol J. 2003;4(1):54-6.

PMID:
12692521
11.
12.

Low cost autologous peripheral blood stem cell transplantation performed in a municipal hospital for a patient with plasma cell leukaemia.

Ghosh K, Gosavi S, Pathare A, Madkaikar M, Rao VB, Mohanty D.

Clin Lab Haematol. 2002 Jun;24(3):187-90.

PMID:
12067286
13.

Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.

Sezer O, Schmid P, Shweigert M, Heider U, Eucker J, Harder H, Sinha P, Radtke H, Possinger K.

Bone Marrow Transplant. 1999 May;23(9):967-9.

14.
15.

Therapeutic outcome of cyclic VAD (vincristine, doxorubicin and dexamethasone) therapy in primary systemic AL amyloidosis patients.

Tazawa K, Matsuda M, Yoshida T, Gono T, Katoh N, Shimojima Y, Ishii W, Fushimi T, Koyama J, Ikeda S.

Intern Med. 2008;47(17):1517-22. Epub 2008 Sep 1.

16.

Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue.

Kojima H, Katsuoka Y, Katsura Y, Suzuki S, Suzukawa K, Hasegawa Y, Nagasawa T.

Int J Hematol. 2006 Aug;84(2):182-5.

PMID:
16926143
17.

Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.

Chen YC, Ho CL, Kao WY, Hwang JM, Sheu LF, Chao TY.

Ann Hematol. 2001 Nov;80(11):647-52.

PMID:
11757723
19.

[Peripheral blood stem cell transplantation for rapidly spreading myeloma].

Ryu T, Asai K, Sugasawa G, Seta K, Kitamura S, Inoue N.

Rinsho Ketsueki. 1995 Aug;36(8):749-54. Japanese.

PMID:
7563608
20.

The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.

Dreger P, Martin S, Kuse R, Sonnen R, Glass B, Kröger N, Parwaresch R, Kneba M, Schmitz N, Haas R.

Hematol J. 2000;1(2):87-94.

PMID:
11920175
Items per page

Supplemental Content

Write to the Help Desk